-Reuters
BioCardia Announces First Cross-Over Patient Treated In CardiAMP Cell Therapy Heart Failure Trial
BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the treatment of the first